Unit of Pediatric Allergy and Respiratory Medicine, Women's and Children's Health Department, University of Padova, 35128 Padova, Italy.
Int J Mol Sci. 2023 Nov 10;24(22):16159. doi: 10.3390/ijms242216159.
Nitric oxide (NO) is produced within the airways and released with exhalation. Nasal NO (nNO) can be measured in a non-invasive way, with different devices and techniques according to the age and cooperation of the patients. Here, we conducted a narrative review of the literature to examine the relationship between nNO and some respiratory diseases with a particular focus on primary ciliary dyskinesia (PCD). A total of 115 papers were assessed, and 50 were eventually included in the review. nNO in PCD is low (below 77 nL/min), and its measurement has a clear diagnostic value when evaluated in a clinically suggestive phenotype. Many studies have evaluated the role of NO as a molecular mediator as well as the association between nNO values and genotype or ciliary function. As far as other respiratory diseases are concerned, nNO is low in chronic rhinosinusitis and cystic fibrosis, while increased values have been found in allergic rhinitis. Nonetheless, the role in the diagnosis and prognosis of these conditions has not been fully clarified.
一氧化氮(NO)在气道中产生,并随呼气释放。鼻一氧化氮(nNO)可以通过不同的设备和技术进行非侵入性测量,具体取决于患者的年龄和配合程度。在这里,我们对文献进行了叙述性综述,以检查 nNO 与一些呼吸系统疾病之间的关系,特别关注原发性纤毛运动障碍(PCD)。共评估了 115 篇论文,最终有 50 篇被纳入综述。PCD 中的 nNO 水平较低(低于 77 nL/min),当在具有临床提示性表型的情况下进行评估时,其测量具有明确的诊断价值。许多研究评估了 NO 作为分子介质的作用,以及 nNO 值与基因型或纤毛功能之间的关联。就其他呼吸系统疾病而言,nNO 在慢性鼻-鼻窦炎和囊性纤维化中较低,而在过敏性鼻炎中则发现了升高的值。尽管如此,其在这些疾病的诊断和预后中的作用尚未完全阐明。